LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 6 of 15: Mean cell count and mean growth rate across biological replicate 3. - Dataset (ID:20242)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
SK-BR-3 | Afatinib | 0.04 | uM | LJP6 | 72 | hr | 1401 | 1437 | 4223 | 0.3404 | 0.0127 |
MCF7 | Afatinib | 1.11 | uM | LJP6 | 72 | hr | 1209 | 2817 | 4093 | 0.6883 | 0.5575 |
Hs 578T | Afatinib | 0.12 | uM | LJP6 | 72 | hr | 658 | 3670 | 3846 | 0.9542 | 0.9448 |
BT-20 | Afatinib | 10.0 | uM | LJP6 | 72 | hr | 1097 | 816 | 3769 | 0.2166 | -0.1051 |
SK-BR-3 | Afatinib | 0.12 | uM | LJP6 | 72 | hr | 1401 | 1416 | 4223 | 0.3354 | 0.0052 |
MDA-MB-231 | Afatinib | 10.0 | uM | LJP6 | 72 | hr | 1235 | 628 | 4513 | 0.1393 | -0.1853 |
Hs 578T | Afatinib | 10.0 | uM | LJP6 | 72 | hr | 658 | 457 | 3846 | 0.1188 | -0.0631 |
MCF 10A | Afatinib | 10.0 | uM | LJP6 | 72 | hr | 962 | 1227 | 10605 | 0.1157 | 0.0275 |
Hs 578T | Afatinib | 0.04 | uM | LJP6 | 72 | hr | 658 | 3556 | 3846 | 0.9247 | 0.9092 |
BT-20 | Afatinib | 3.33 | uM | LJP6 | 72 | hr | 1097 | 3253 | 3769 | 0.8631 | 0.8068 |
MDA-MB-231 | Afatinib | 1.11 | uM | LJP6 | 72 | hr | 1235 | 2739 | 4513 | 0.6069 | 0.4587 |
MCF7 | Afatinib | 0.37 | uM | LJP6 | 72 | hr | 1209 | 3723 | 4093 | 0.9096 | 0.8717 |
MDA-MB-231 | Afatinib | 0.37 | uM | LJP6 | 72 | hr | 1235 | 3577 | 4513 | 0.7926 | 0.7144 |
MCF 10A | Afatinib | 1.11 | uM | LJP6 | 72 | hr | 962 | 1383 | 10605 | 0.1304 | 0.0436 |
MDA-MB-231 | Afatinib | 3.33 | uM | LJP6 | 72 | hr | 1235 | 2749 | 4513 | 0.6090 | 0.4616 |
MCF7 | Afatinib | 3.33 | uM | LJP6 | 72 | hr | 1209 | 3086 | 4093 | 0.7541 | 0.6510 |
MDA-MB-231 | Afatinib | 0.12 | uM | LJP6 | 72 | hr | 1235 | 4078 | 4513 | 0.9036 | 0.8673 |
MCF 10A | Afatinib | 3.33 | uM | LJP6 | 72 | hr | 962 | 1483 | 10605 | 0.1399 | 0.0541 |
BT-20 | Afatinib | 0.04 | uM | LJP6 | 72 | hr | 1097 | 2874 | 3769 | 0.7625 | 0.6650 |
MCF 10A | Afatinib | 0.12 | uM | LJP6 | 72 | hr | 962 | 1521 | 10605 | 0.1435 | 0.0580 |
MCF7 | Afatinib | 0.12 | uM | LJP6 | 72 | hr | 1209 | 3666 | 4093 | 0.8958 | 0.8520 |
SK-BR-3 | Afatinib | 0.37 | uM | LJP6 | 72 | hr | 1401 | 1401 | 4223 | 0.3318 | -0.0002 |
Hs 578T | Alpelisib | 10.0 | uM | LJP5 | 72 | hr | 658 | 2213 | 3846 | 0.5755 | 0.4878 |
MCF7 | Alpelisib | 10.0 | uM | LJP5 | 72 | hr | 1209 | 1130 | 4093 | 0.2762 | -0.0275 |
BT-20 | Alpelisib | 1.11 | uM | LJP5 | 72 | hr | 1097 | 2083 | 3769 | 0.5527 | 0.3690 |